Free Trial

Is Eli Lilly a Buy After Weak Earnings and CVS-Novo Partnership?

Key Points

  • Eli Lilly shares dropped by double digits after its latest earnings report.
  • The announcement of a key partnership between CVS Health and Novo Nordisk exacerbated the drop.
  • Is Lilly still in the driver's seat in the GLP-1 market, and how should investors view the stock after this news?
  • MarketBeat previews the top five stocks to own by June 1st.

unlock icon  Upgrade Now

This premium article is available to MarketBeat All Access subscribers only. Log in to your account or sign up below.

Already have an account? Log in here.

Should You Invest $1,000 in Eli Lilly and Company Right Now?

Before you consider Eli Lilly and Company, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Eli Lilly and Company wasn't on the list.

While Eli Lilly and Company currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google Cover

Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.

Get This Free Report
Leo Miller
About The Author

Leo Miller

Contributing Author

Fundamental Analysis, Economics, Industry and Sector Analysis

Like this article? Share it with a colleague.

Companies Mentioned in This Article

CompanyMarketRank™Current PricePrice ChangeDividend YieldP/E RatioConsensus RatingConsensus Price Target
Eli Lilly and Company (LLY)
4.9806 of 5 stars
$776.70+0.2%0.77%66.36Moderate Buy$1,002.80
CVS Health (CVS)
4.9761 of 5 stars
$66.44+0.3%4.00%18.17Moderate Buy$75.13
Novo Nordisk A/S (NVO)
4.6998 of 5 stars
$68.10+2.7%2.39%20.73Hold$135.00
Compare These Stocks  Add These Stocks to My Watchlist 

Featured Articles and Offers

Recent Videos

Palantir’s Big Moves: Profit-Taking, Price Targets & AI Potential
Buy Early: 3 Tech Trends With Millionaire-Making Potential
SMCI Stumbles on Earnings: Why Some Investors Still Want In

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines